Starboard Value
to date difficile vaccine studies have failed to achieve its primary | Starboard Value
Company
Deck Type
Sector
Industry
Deck date
October 2024
Slide
24 of 74
Related slides by other companies
BioNTech
Results
November 2020
highlights covid | BioNTech
Dare Bioscience
Investor Presentation
February 2023
oral provided a compelling proof of concept for | Dare Bioscience
BioNTech
Results
May 2021
highlights from first quarter and beyond first patients dosed in multiple first in human studies executional excellence in infectious disease with covid vaccine | BioNTech
Hillevax
IPO
April 2022
potential billion dollar commercial opportunity | Hillevax
Other recent decks by Starboard Value
See all presentations (4 decks)
Activist
October 2024
Activist
October 2024
Activist
May 2012
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io